The In-vitro Diagnostic Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global In-vitro Diagnostic Services market size is estimated to be worth US$ 66330 million in 2021 and is forecast to a readjusted size of USD 88020 million by 2028 with a CAGR of 4.1% during review period. Hospitals accounting for % of the In-vitro Diagnostic Services global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Infectious Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of In-vitro Diagnostic Services include BioRad, DexCom, Nova Biomedical, OraSure, and Pearl Pathways, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
In-vitro Diagnostic Services market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Market segment by Application, can be divided into
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
Market segment by players, this report covers
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
Sysmex
Thermofisher
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe In-vitro Diagnostic Services product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In-vitro Diagnostic Services, with revenue, gross margin and global market share of In-vitro Diagnostic Services from 2019 to 2022.
Chapter 3, the In-vitro Diagnostic Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and In-vitro Diagnostic Services market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe In-vitro Diagnostic Services research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of In-vitro Diagnostic Services
1.2 Classification of In-vitro Diagnostic Services by Type
1.2.1 Overview: Global In-vitro Diagnostic Services Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global In-vitro Diagnostic Services Revenue Market Share by Type in 2021
1.2.3 Infectious Testing
1.2.4 Diabetes Testing
1.2.5 Molecular Testing
1.2.6 Tissue Testing
1.3 Global In-vitro Diagnostic Services Market by Application
1.3.1 Overview: Global In-vitro Diagnostic Services Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Point-Of-Care Testing
1.3.4 Laboratories
1.3.5 Academic Institutes
1.4 Global In-vitro Diagnostic Services Market Size & Forecast
1.5 Global In-vitro Diagnostic Services Market Size and Forecast by Region
1.5.1 Global In-vitro Diagnostic Services Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global In-vitro Diagnostic Services Market Size by Region, (2017-2022)
1.5.3 North America In-vitro Diagnostic Services Market Size and Prospect (2017-2028)
1.5.4 Europe In-vitro Diagnostic Services Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific In-vitro Diagnostic Services Market Size and Prospect (2017-2028)
1.5.6 South America In-vitro Diagnostic Services Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa In-vitro Diagnostic Services Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 In-vitro Diagnostic Services Market Drivers
1.6.2 In-vitro Diagnostic Services Market Restraints
1.6.3 In-vitro Diagnostic Services Trends Analysis
2 Company Profiles
2.1 BioRad
2.1.1 BioRad Details
2.1.2 BioRad Major Business
2.1.3 BioRad In-vitro Diagnostic Services Product and Solutions
2.1.4 BioRad In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 BioRad Recent Developments and Future Plans
2.2 DexCom
2.2.1 DexCom Details
2.2.2 DexCom Major Business
2.2.3 DexCom In-vitro Diagnostic Services Product and Solutions
2.2.4 DexCom In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 DexCom Recent Developments and Future Plans
2.3 Nova Biomedical
2.3.1 Nova Biomedical Details
2.3.2 Nova Biomedical Major Business
2.3.3 Nova Biomedical In-vitro Diagnostic Services Product and Solutions
2.3.4 Nova Biomedical In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Nova Biomedical Recent Developments and Future Plans
2.4 OraSure
2.4.1 OraSure Details
2.4.2 OraSure Major Business
2.4.3 OraSure In-vitro Diagnostic Services Product and Solutions
2.4.4 OraSure In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 OraSure Recent Developments and Future Plans
2.5 Pearl Pathways
2.5.1 Pearl Pathways Details
2.5.2 Pearl Pathways Major Business
2.5.3 Pearl Pathways In-vitro Diagnostic Services Product and Solutions
2.5.4 Pearl Pathways In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pearl Pathways Recent Developments and Future Plans
2.6 Phenomenex
2.6.1 Phenomenex Details
2.6.2 Phenomenex Major Business
2.6.3 Phenomenex In-vitro Diagnostic Services Product and Solutions
2.6.4 Phenomenex In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Phenomenex Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen In-vitro Diagnostic Services Product and Solutions
2.7.4 Qiagen In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Roche Diagnostics
2.8.1 Roche Diagnostics Details
2.8.2 Roche Diagnostics Major Business
2.8.3 Roche Diagnostics In-vitro Diagnostic Services Product and Solutions
2.8.4 Roche Diagnostics In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Roche Diagnostics Recent Developments and Future Plans
2.9 Siemens
2.9.1 Siemens Details
2.9.2 Siemens Major Business
2.9.3 Siemens In-vitro Diagnostic Services Product and Solutions
2.9.4 Siemens In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Siemens Recent Developments and Future Plans
2.10 Sysmex
2.10.1 Sysmex Details
2.10.2 Sysmex Major Business
2.10.3 Sysmex In-vitro Diagnostic Services Product and Solutions
2.10.4 Sysmex In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sysmex Recent Developments and Future Plans
2.11 Thermofisher
2.11.1 Thermofisher Details
2.11.2 Thermofisher Major Business
2.11.3 Thermofisher In-vitro Diagnostic Services Product and Solutions
2.11.4 Thermofisher In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Thermofisher Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-vitro Diagnostic Services Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 In-vitro Diagnostic Services Players Market Share in 2021
3.2.2 Top 10 In-vitro Diagnostic Services Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 In-vitro Diagnostic Services Players Head Office, Products and Services Provided
3.4 In-vitro Diagnostic Services Mergers & Acquisitions
3.5 In-vitro Diagnostic Services New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In-vitro Diagnostic Services Revenue and Market Share by Type (2017-2022)
4.2 Global In-vitro Diagnostic Services Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global In-vitro Diagnostic Services Revenue Market Share by Application (2017-2022)
5.2 Global In-vitro Diagnostic Services Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America In-vitro Diagnostic Services Revenue by Type (2017-2028)
6.2 North America In-vitro Diagnostic Services Revenue by Application (2017-2028)
6.3 North America In-vitro Diagnostic Services Market Size by Country
6.3.1 North America In-vitro Diagnostic Services Revenue by Country (2017-2028)
6.3.2 United States In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
6.3.3 Canada In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
6.3.4 Mexico In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe In-vitro Diagnostic Services Revenue by Type (2017-2028)
7.2 Europe In-vitro Diagnostic Services Revenue by Application (2017-2028)
7.3 Europe In-vitro Diagnostic Services Market Size by Country
7.3.1 Europe In-vitro Diagnostic Services Revenue by Country (2017-2028)
7.3.2 Germany In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
7.3.3 France In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
7.3.4 United Kingdom In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
7.3.5 Russia In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
7.3.6 Italy In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In-vitro Diagnostic Services Revenue by Type (2017-2028)
8.2 Asia-Pacific In-vitro Diagnostic Services Revenue by Application (2017-2028)
8.3 Asia-Pacific In-vitro Diagnostic Services Market Size by Region
8.3.1 Asia-Pacific In-vitro Diagnostic Services Revenue by Region (2017-2028)
8.3.2 China In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
8.3.3 Japan In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
8.3.4 South Korea In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
8.3.5 India In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
8.3.7 Australia In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America In-vitro Diagnostic Services Revenue by Type (2017-2028)
9.2 South America In-vitro Diagnostic Services Revenue by Application (2017-2028)
9.3 South America In-vitro Diagnostic Services Market Size by Country
9.3.1 South America In-vitro Diagnostic Services Revenue by Country (2017-2028)
9.3.2 Brazil In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
9.3.3 Argentina In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In-vitro Diagnostic Services Revenue by Type (2017-2028)
10.2 Middle East & Africa In-vitro Diagnostic Services Revenue by Application (2017-2028)
10.3 Middle East & Africa In-vitro Diagnostic Services Market Size by Country
10.3.1 Middle East & Africa In-vitro Diagnostic Services Revenue by Country (2017-2028)
10.3.2 Turkey In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
10.3.4 UAE In-vitro Diagnostic Services Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global In-vitro Diagnostic Services Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global In-vitro Diagnostic Services Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market In-vitro Diagnostic Services Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global In-vitro Diagnostic Services Revenue (USD Million) by Region (2017-2022)
Table 5. Global In-vitro Diagnostic Services Revenue Market Share by Region (2023-2028)
Table 6. BioRad Corporate Information, Head Office, and Major Competitors
Table 7. BioRad Major Business
Table 8. BioRad In-vitro Diagnostic Services Product and Solutions
Table 9. BioRad In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. DexCom Corporate Information, Head Office, and Major Competitors
Table 11. DexCom Major Business
Table 12. DexCom In-vitro Diagnostic Services Product and Solutions
Table 13. DexCom In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Nova Biomedical Corporate Information, Head Office, and Major Competitors
Table 15. Nova Biomedical Major Business
Table 16. Nova Biomedical In-vitro Diagnostic Services Product and Solutions
Table 17. Nova Biomedical In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. OraSure Corporate Information, Head Office, and Major Competitors
Table 19. OraSure Major Business
Table 20. OraSure In-vitro Diagnostic Services Product and Solutions
Table 21. OraSure In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pearl Pathways Corporate Information, Head Office, and Major Competitors
Table 23. Pearl Pathways Major Business
Table 24. Pearl Pathways In-vitro Diagnostic Services Product and Solutions
Table 25. Pearl Pathways In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Phenomenex Corporate Information, Head Office, and Major Competitors
Table 27. Phenomenex Major Business
Table 28. Phenomenex In-vitro Diagnostic Services Product and Solutions
Table 29. Phenomenex In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Qiagen Corporate Information, Head Office, and Major Competitors
Table 31. Qiagen Major Business
Table 32. Qiagen In-vitro Diagnostic Services Product and Solutions
Table 33. Qiagen In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. Roche Diagnostics Major Business
Table 36. Roche Diagnostics In-vitro Diagnostic Services Product and Solutions
Table 37. Roche Diagnostics In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Siemens Corporate Information, Head Office, and Major Competitors
Table 39. Siemens Major Business
Table 40. Siemens In-vitro Diagnostic Services Product and Solutions
Table 41. Siemens In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sysmex Corporate Information, Head Office, and Major Competitors
Table 43. Sysmex Major Business
Table 44. Sysmex In-vitro Diagnostic Services Product and Solutions
Table 45. Sysmex In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Thermofisher Corporate Information, Head Office, and Major Competitors
Table 47. Thermofisher Major Business
Table 48. Thermofisher In-vitro Diagnostic Services Product and Solutions
Table 49. Thermofisher In-vitro Diagnostic Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Global In-vitro Diagnostic Services Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 51. Global In-vitro Diagnostic Services Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 52. Breakdown of In-vitro Diagnostic Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. In-vitro Diagnostic Services Players Head Office, Products and Services Provided
Table 54. In-vitro Diagnostic Services Mergers & Acquisitions in the Past Five Years
Table 55. In-vitro Diagnostic Services New Entrants and Expansion Plans
Table 56. Global In-vitro Diagnostic Services Revenue (USD Million) by Type (2017-2022)
Table 57. Global In-vitro Diagnostic Services Revenue Share by Type (2017-2022)
Table 58. Global In-vitro Diagnostic Services Revenue Forecast by Type (2023-2028)
Table 59. Global In-vitro Diagnostic Services Revenue by Application (2017-2022)
Table 60. Global In-vitro Diagnostic Services Revenue Forecast by Application (2023-2028)
Table 61. North America In-vitro Diagnostic Services Revenue by Type (2017-2022) & (USD Million)
Table 62. North America In-vitro Diagnostic Services Revenue by Type (2023-2028) & (USD Million)
Table 63. North America In-vitro Diagnostic Services Revenue by Application (2017-2022) & (USD Million)
Table 64. North America In-vitro Diagnostic Services Revenue by Application (2023-2028) & (USD Million)
Table 65. North America In-vitro Diagnostic Services Revenue by Country (2017-2022) & (USD Million)
Table 66. North America In-vitro Diagnostic Services Revenue by Country (2023-2028) & (USD Million)
Table 67. Europe In-vitro Diagnostic Services Revenue by Type (2017-2022) & (USD Million)
Table 68. Europe In-vitro Diagnostic Services Revenue by Type (2023-2028) & (USD Million)
Table 69. Europe In-vitro Diagnostic Services Revenue by Application (2017-2022) & (USD Million)
Table 70. Europe In-vitro Diagnostic Services Revenue by Application (2023-2028) & (USD Million)
Table 71. Europe In-vitro Diagnostic Services Revenue by Country (2017-2022) & (USD Million)
Table 72. Europe In-vitro Diagnostic Services Revenue by Country (2023-2028) & (USD Million)
Table 73. Asia-Pacific In-vitro Diagnostic Services Revenue by Type (2017-2022) & (USD Million)
Table 74. Asia-Pacific In-vitro Diagnostic Services Revenue by Type (2023-2028) & (USD Million)
Table 75. Asia-Pacific In-vitro Diagnostic Services Revenue by Application (2017-2022) & (USD Million)
Table 76. Asia-Pacific In-vitro Diagnostic Services Revenue by Application (2023-2028) & (USD Million)
Table 77. Asia-Pacific In-vitro Diagnostic Services Revenue by Region (2017-2022) & (USD Million)
Table 78. Asia-Pacific In-vitro Diagnostic Services Revenue by Region (2023-2028) & (USD Million)
Table 79. South America In-vitro Diagnostic Services Revenue by Type (2017-2022) & (USD Million)
Table 80. South America In-vitro Diagnostic Services Revenue by Type (2023-2028) & (USD Million)
Table 81. South America In-vitro Diagnostic Services Revenue by Application (2017-2022) & (USD Million)
Table 82. South America In-vitro Diagnostic Services Revenue by Application (2023-2028) & (USD Million)
Table 83. South America In-vitro Diagnostic Services Revenue by Country (2017-2022) & (USD Million)
Table 84. South America In-vitro Diagnostic Services Revenue by Country (2023-2028) & (USD Million)
Table 85. Middle East & Africa In-vitro Diagnostic Services Revenue by Type (2017-2022) & (USD Million)
Table 86. Middle East & Africa In-vitro Diagnostic Services Revenue by Type (2023-2028) & (USD Million)
Table 87. Middle East & Africa In-vitro Diagnostic Services Revenue by Application (2017-2022) & (USD Million)
Table 88. Middle East & Africa In-vitro Diagnostic Services Revenue by Application (2023-2028) & (USD Million)
Table 89. Middle East & Africa In-vitro Diagnostic Services Revenue by Country (2017-2022) & (USD Million)
Table 90. Middle East & Africa In-vitro Diagnostic Services Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. In-vitro Diagnostic Services Picture
Figure 2. Global In-vitro Diagnostic Services Revenue Market Share by Type in 2021
Figure 3. Infectious Testing
Figure 4. Diabetes Testing
Figure 5. Molecular Testing
Figure 6. Tissue Testing
Figure 7. In-vitro Diagnostic Services Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Point-Of-Care Testing Picture
Figure 10. Laboratories Picture
Figure 11. Academic Institutes Picture
Figure 12. Global In-vitro Diagnostic Services Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global In-vitro Diagnostic Services Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global In-vitro Diagnostic Services Revenue Market Share by Region (2017-2028)
Figure 15. Global In-vitro Diagnostic Services Revenue Market Share by Region in 2021
Figure 16. North America In-vitro Diagnostic Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe In-vitro Diagnostic Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific In-vitro Diagnostic Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America In-vitro Diagnostic Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa In-vitro Diagnostic Services Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. In-vitro Diagnostic Services Market Drivers
Figure 22. In-vitro Diagnostic Services Market Restraints
Figure 23. In-vitro Diagnostic Services Market Trends
Figure 24. BioRad Recent Developments and Future Plans
Figure 25. DexCom Recent Developments and Future Plans
Figure 26. Nova Biomedical Recent Developments and Future Plans
Figure 27. OraSure Recent Developments and Future Plans
Figure 28. Pearl Pathways Recent Developments and Future Plans
Figure 29. Phenomenex Recent Developments and Future Plans
Figure 30. Qiagen Recent Developments and Future Plans
Figure 31. Roche Diagnostics Recent Developments and Future Plans
Figure 32. Siemens Recent Developments and Future Plans
Figure 33. Sysmex Recent Developments and Future Plans
Figure 34. Thermofisher Recent Developments and Future Plans
Figure 35. Global In-vitro Diagnostic Services Revenue Share by Players in 2021
Figure 36. In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players In-vitro Diagnostic Services Revenue Market Share in 2021
Figure 38. Global Top 10 Players In-vitro Diagnostic Services Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global In-vitro Diagnostic Services Revenue Share by Type in 2021
Figure 41. Global In-vitro Diagnostic Services Market Share Forecast by Type (2023-2028)
Figure 42. Global In-vitro Diagnostic Services Revenue Share by Application in 2021
Figure 43. Global In-vitro Diagnostic Services Market Share Forecast by Application (2023-2028)
Figure 44. North America In-vitro Diagnostic Services Sales Market Share by Type (2017-2028)
Figure 45. North America In-vitro Diagnostic Services Sales Market Share by Application (2017-2028)
Figure 46. North America In-vitro Diagnostic Services Revenue Market Share by Country (2017-2028)
Figure 47. United States In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe In-vitro Diagnostic Services Sales Market Share by Type (2017-2028)
Figure 51. Europe In-vitro Diagnostic Services Sales Market Share by Application (2017-2028)
Figure 52. Europe In-vitro Diagnostic Services Revenue Market Share by Country (2017-2028)
Figure 53. Germany In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific In-vitro Diagnostic Services Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific In-vitro Diagnostic Services Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific In-vitro Diagnostic Services Revenue Market Share by Region (2017-2028)
Figure 61. China In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America In-vitro Diagnostic Services Sales Market Share by Type (2017-2028)
Figure 68. South America In-vitro Diagnostic Services Sales Market Share by Application (2017-2028)
Figure 69. South America In-vitro Diagnostic Services Revenue Market Share by Country (2017-2028)
Figure 70. Brazil In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa In-vitro Diagnostic Services Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa In-vitro Diagnostic Services Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa In-vitro Diagnostic Services Revenue Market Share by Country (2017-2028)
Figure 75. Turkey In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE In-vitro Diagnostic Services Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source